E-Book, Englisch, 224 Seiten, Web PDF
Hermann / Mornex / Alexander Human Tumours Secreting Catecholamines
1. Auflage 2017
ISBN: 978-1-4832-8261-9
Verlag: Elsevier Science & Techn.
Format: PDF
Kopierschutz: 1 - PDF Watermark
Clinical and Physiopathological Study of the Pheochromocytomas
E-Book, Englisch, 224 Seiten, Web PDF
ISBN: 978-1-4832-8261-9
Verlag: Elsevier Science & Techn.
Format: PDF
Kopierschutz: 1 - PDF Watermark
Human Tumors Secreting Catecholamines: Clinical and Physiopathological Study of the Pheochromocytomas focuses on the characteristics, manifestations, diagnosis, and treatment of pheochromocytomas. The manuscript first offers information on cardiovascular manifestations, metabolic and endocrine manifestations, and unusual clinical manifestations and complications. Discussions focus on permanent arterial hypertension, disturbances of glycoregulation, cardiovascular complications, and major circulatory accidents. The book then examines anatomical forms, including intrathoracic, para-aortic, urinary bladder, multiple, and malignant pheochromocytomas. The publication ponders on inherited forms and pheochromocytomas in children and pregnant women and the diagnosis and treatment of pheochromocytoma. The text also takes a look at pathological anatomy, biological investigations, and physiopathology. Topics include cardiovascular symptoms, dynamics of tumor secretion, histochemical problems, and hormone content of tumors. The manuscript is a dependable reference for readers interested in the study of pheochromocytomas.
Autoren/Hrsg.
Weitere Infos & Material
1;Front Cover;1
2;Human Tumours Secreting Catecholamines: Clinical and Physiopathological Study of the Pheochromocytomas;4
3;Copyright Page;5
4;Table of Contents;6
5;Introduction;10
6;Historical and general;12
7;PART I: CLINICAL FEATURES;16
7.1;CHAPTER 1. CARDIOVASCULAR MANIFESTATIONS;18
7.1.1;Paroxysmal hypertensive crises;18
7.1.2;Permanent arterial hypertension;23
7.2;CHAPTER 2. METABOLIC AND ENDOCRINE MANIFESTATIONS;34
7.2.1;Thyroid manifestations;34
7.2.2;Disturbances of glycoregulation;36
7.2.3;Various endocrine and metabolic manifestations;41
7.3;CHAPTER 3. UNUSUAL CLINICAL MANIFESTATIONS AND COMPLICATIONS;43
7.3.1;Unusual semeiological features;43
7.3.2;Asymptomatic forms;46
7.3.3;Cardiovascular complications;48
7.3.4;Major circulatory accidents;51
7.4;CHAPTER 4. ANATOMICAL FORMS;59
7.4.1;Non-expansive intra-suprarenal pheochromocytoma;60
7.4.2;Extra-suprarenal pheochromocytomas;67
7.4.3;Para-aortic pheochromocytomas;70
7.4.4;Intrathoracic pheochromocytomas;76
7.4.5;Urinary bladder pheochromocytomas;79
7.4.6;Multiple pheochromocytomas;83
7.4.7;Malignant pheochromocytomas;88
7.5;CHAPTER 5. INHERITED FORMS AND PHEOCHROMOCYTOMAS IN CHILDREN AND PREGNANT WOMEN;94
7.5.1;Familial pheochromocytoma;94
7.5.2;Pheochromocytoma and neurofibromatosis;99
7.5.3;Pheochromocytoma in children;104
7.5.4;Pheochromocytoma and pregnancy;108
7.5.5;Benign pheochromocytoma associated with cancer;112
8;PART II: DIAGNOSIS AND TREATMENT;113
8.1;CHAPTER 1. DIAGNOSIS;114
8.1.1;Clinical stage;114
8.1.2;Pharmacodynamic stage;118
8.1.3;Estimation of the secretory products of the tumour and their metabolites;124
8.1.4;Routine methods of estimation for the diagnosis of pheochromocytoma;133
8.1.5;Radiological stage;149
8.1.6;Diagnosis: summing-up and conclusions;151
8.2;CHAPTER 2. TREATMENT;154
8.2.1;Medical treatment;154
8.2.2;Surgical treatment;155
8.2.3;Treatment of malignant pheochromocytomas;162
9;PART III: ANATOMICAL AND BIOLOGICAL INVESTIGATIONS;163
9.1;CHAPTER 1. PATHOLOGICAL ANATOMY;166
9.1.1;General considerations;166
9.1.2;Staining reactions;167
9.1.3;Cytological examination;168
9.1.4;Malignant pheochromocytoma;169
9.1.5;Histological renal lesions;172
9.2;CHAPTER 2. BIOLOGICAL INVESTIGATIONS;173
9.2.1;Methods of preparation;173
9.2.2;Extraction of the hormones;174
9.2.3;Hormone content of tumours;175
9.2.4;Dynamics of tumour secretion;180
9.2.5;The biological basis for clinical signs;184
9.2.6;Histochemical problems;194
10;PART IV: PHYSIOPATHOLOGY;198
10.1;General secretory behaviour of the tumour;199
10.2;Cardiovascular symptoms;200
10.3;Endocrine and metabolic manifestations;204
10.4;Miscellaneous manifestations;208
11;INDEX OF CASES;214
12;BIBLIOGRAPHY;220
13;SUBJECT INDEX;247
14;OTHER VOLUMES IN THIS SERIES;249




